Calian Group (TSE:CGY) Price Target Raised to C$66.00

Calian Group (TSE:CGY) had its target price boosted by Desjardins from C$59.00 to C$66.00 in a research note released on Thursday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

CGY has been the topic of several other reports. Canaccord Genuity Group lifted their price target on shares of Calian Group from C$60.00 to C$63.00 and gave the company a “buy” rating in a research note on Thursday. CIBC lifted their target price on Calian Group from C$59.00 to C$62.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Ventum Financial increased their price target on Calian Group from C$58.00 to C$62.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Royal Bank Of Canada raised their price target on Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a research note on Thursday. Five analysts have rated the stock with a Buy rating, According to MarketBeat, the company presently has an average rating of “Buy” and an average price target of C$63.80.

Calian Group Price Performance

TSE CGY opened at C$54.11 on Thursday. The firm’s 50 day moving average is C$50.48 and its 200-day moving average is C$48.76. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The company has a market capitalization of C$614.15 million, a PE ratio of 30.74, a price-to-earnings-growth ratio of 2.50 and a beta of 0.43. Calian Group has a 12-month low of C$37.70 and a 12-month high of C$54.35.

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.